Forty Seven, Inc., a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced proof-of-concept data from two...

Genomic Health, Inc. (NASDAQ: GHDX) today announced that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage...

Nektar Therapeutics (Nasdaq: NKTR) and Bristol-Myers Squibb (NYSE: BMY) today announced presentation of preliminary data from the ongoing PIVOT Phase 1/2 Study, which is evaluating the combination...

New Novartis data from two long-term Treatment-free Remission (TFR) studies in patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase (CP) will be...

DVIGear, a leading manufacturer of digital connectivity products, is exhibiting the latest SDVoE technology in its DisplayNet® AV-Over-10GbE distribution platform at InfoComm 2018 from June 8-10...

Mylan N.V. (NASDAQ: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that 48-week results from the HERITAGE study will be presented at the 2018 American Society of Clinical...

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced findings from an interim analysis of the Phase 3 iNNOVATE (PCYC-1127) study evaluating IMBRUVICA®...

Nu Skin Enterprises, Inc. (NYSE: NUS) today announced Vice President of Investor Relations Scott Pond will present at Baird's 2018 Global Consumer, Technology & Services Conference in New York on...

Macerich® (NYSE: MAC) today announced that Tom O'Hern, Sr. Executive Vice President, Chief Financial Officer and Treasurer, will present at REITWeek 2018: NAREIT's Investor Forum® in New York,...

Florida Hospice & Palliative Care Association announced six winners of the Awards of Excellence in concurrence with their Forum 2018 'Care Kaleidoscope' annual conference. The awards recognize the...